Literature DB >> 6426392

6-hydroxydopamine does not reduce molecular oxygen directly, but requires a coreductant.

P Gee, A J Davison.   

Abstract

The autoxidation of 6-hydroxydopamine (6HODA) was virtually blocked (k2 less than 10(-15) M-1 S-1 at pH 8.0, ionic strength 0.04) by the simultaneous presence of diethylenetriaminepentaacetic acid (DTPA), catalase, and superoxide dismutase (SOD). No quinone product or oxygen consumption was detectable after 12 min under these conditions. Thus, if 6HODA is to react with molecular oxygen at a measurable rate, some other redox species is required as a coreductant. The subsequent addition of formate or mannitol proved capable of overcoming the total inhibition induced by the mixture of catalase, SOD, and DTPA. The simplest interpretation of the data is that most of the autoxidation of 6HODA, as commonly observed, involves successive reduction of a series of metal-bound species of oxygen; the actual transfer of electrons occurring within a ternary reductant-metal-oxygen transition state.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6426392     DOI: 10.1016/0003-9861(84)90373-4

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  3 in total

Review 1.  The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention.

Authors:  Joshua D Lambert; Ryan J Elias
Journal:  Arch Biochem Biophys       Date:  2010-06-15       Impact factor: 4.013

2.  One-electron reduction of 6-hydroxydopamine quinone is essential in 6-hydroxydopamine neurotoxicity.

Authors:  Monica Villa; Patricia Muñoz; Ulises Ahumada-Castro; Irmgard Paris; Ana Jiménez; Isabel Martínez; Francisca Sevilla; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2013-02-06       Impact factor: 3.911

3.  Semiquinone anion radicals of catechol(amine)s, catechol estrogens, and their metal ion complexes.

Authors:  B Kalyanaraman; C C Felix; R C Sealy
Journal:  Environ Health Perspect       Date:  1985-12       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.